|
1 |
30 04 2026 |
OneSource Speciality Pharma shares jump over 3% on securing EU GMP certificate for SPD facility |
Upstox |
India |
|
2 |
30 04 2026 |
Rajasthan drug controller bans 7 medicines, suspends licenses of 3 Pharma units |
News Live Tv |
India |
|
3 |
30 04 2026 |
Nandini Piramal warns prolonged West Asia war may raise input costs |
Economic Times |
India |
|
4 |
30 04 2026 |
Dr Reddy’s receives Health Canada approval for generic Semaglutide Injection |
Express Pharma |
India |
|
5 |
30 04 2026 |
Pfizer secures deals to keep heart drug free of generic rivals until 2031 |
Health World(Economic Times) |
India |
|
6 |
30 04 2026 |
Sun Pharma puts in place team to integrate Organon global operations |
The Hindu(Business Line) |
India |
|
7 |
30 04 2026 |
Webinar to be hosted on the future of pharma industry |
The Hindu |
India |
|
8 |
30 04 2026 |
Parliamentary Panel asks Ministry of Ayush to come up with realistic projections at BE stage |
Pharmabiz |
India |
|
9 |
30 04 2026 |
Fake Mounjaro scam:Unapproved 'Toneup' Tirzepatide shots sold via IndiaMART |
Medical dialogues |
India |
|
10 |
29 04 2026 |
India–New Zealand FTA set to boost pharma exports |
Pharmabiz |
India |
|
11 |
29 04 2026 |
US FDA grants marketing authorization to Essilor Stellest as the spectacle lens for myopia control in India |
Pharmabiz |
India |
|
12 |
29 04 2026 |
How Chinese oral GLP-1 drugs may reshape India's obesity drug market |
Business Standard |
India |
|
13 |
29 04 2026 |
AKUMS launches Aztreonam-Avibactam Injection for multidrug-resistant infections |
Express Pharma |
India |
|
14 |
29 04 2026 |
Who Really Makes Your Medicines? A Simple Guide To Pharma Business Models |
ABP News |
India |
|
15 |
29 04 2026 |
Strengthening Adult Immunization in India PCV20 and the changing landscape of Pneumococcal disease prevention |
Medical Dialogues |
India |
|
16 |
29 04 2026 |
Oxford University strikes new malaria vaccine pact with Serum Institute of India |
Economic Times |
India |
|
17 |
28 04 2026 |
Gujarat govt strengthens drugs and cosmetics regulation with key appointments |
Pharmabiz |
India |
|
18 |
28 04 2026 |
Pharma leaders hail Jan Vishwas Act’s ‘trust-based’ shift while red-flagging implementation hurdles |
Pharmabiz |
India |
|
19 |
28 04 2026 |
Sun Pharma to acquire Organon in $11.75 billion all-cash deal |
Indian Pharma Post |
India |
|
20 |
28 04 2026 |
Uttar Pradesh Approves 17 Pharma Projects, Targets ₹2000 Crore Investment and 10,000 Jobs Boost |
India Master Mind |
India |
